http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9108737-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0ef049605214ab2d6cbb74d055c351e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-51
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C259-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-24
filingDate 1990-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2714356f60e9405acf1329855d31047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_409427bc20472cde6d6194d4e5da95f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_995f76001c5d2e0e2627c2a89a19cbd4
publicationDate 1992-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9108737-A3
titleOfInvention Pharmacologically active amide carboxylate derivatives
abstract This invention relates to compounds having pharmacological activity, processes for their preparation, compositions containing them and methods of treatment involving their use. In its broadest aspect, the invention is concerned with compounds, having general formula (I) in which R1 represents an alkyl C¿1-18? group optionally substituted by an aryl group or hydroxy or a cycloalkyl C3-6 group, R?2¿ represents an alkyl C¿1-18? group optionally substituted by an aryl group, or R?2¿ represents a group -CH¿2¿-X-R4 wherein X represents O or S, and R4 represents hydrogen, an aryl group, or an alkyl or alkenyl C¿1-18? group optionally substituted by an aryl group, R?3¿ represents OH, alkoxy C¿1-6? or -NHR?31¿, wherein R31 represents hydrogen, alkyl C¿1-6?, OH or alkoxy C1-6 optionally substituted by an aryl group, R?5¿ represents hydrogen, an aryl group or an alkyl or alkenyl C¿1-18? group optionally substituted by an aryl group, n represents 0, 1, 2 or 3, p represents 0, 1 or 2, q represents 0 or 1, Y represents -CHR?6¿-, -CH=CH-, O or S, in which R6 represents hydrogen, an aryl group or an alkyl or alkenyl C¿1-18? group optionally substituted by an aryl group, and pharmaceutically acceptable derivates thereof.
priorityDate 1989-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0226304-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 52.